New JAMA Study Ties County-Level Medical Debt to Later-Stage Cancer Diagnoses

Since the Commonwealth Fund survey covered this week found that one in three insured Americans are paying off medical debt, a new study published Oct. 1 in JAMA Network Open adds a grimmer layer: counties with heavier medical debt burdens also have higher rates of late-stage cancer diagnosis.

Researchers analyzed 2,958 U.S. counties, linking 2016 county-level medical debt data to age-adjusted cancer incidence rates from January 2017 through December 2021, according to MedPage Today. The study covered nine cancers with screening guidelines or clear early symptoms: lung, colorectal, cervical, breast, prostate, melanoma, kidney, bladder, and head and neck.

The numbers are stark. Each 10-percentage-point increase in county-level medical debt was linked to 5.15 additional late-stage lung cancer cases per 100,000 person-years, the largest effect of any cancer type studied. Smaller but still statistically significant increases, all below a P-value of 0.001, showed up for colorectal, cervical, melanoma, kidney, bladder, and head and neck cancers, according to both MedPage Today and Medscape.

Across the 2,958 counties studied, medical debt prevalence ranged from about 1% to 52%, with an average of 21% in collections, per radiologybusiness. Debt burden ran higher in rural counties, which made up 61% of the sample, and in more socially vulnerable communities. Average primary care physician density across counties was 0.54.

What the researchers say caused it

The study's authors, including Xin Hu, PhD, of Emory University's Department of Radiation Oncology, and Changchuan Jiang, MD, MPH, of UT Southwestern Medical Center, wrote that medical debt likely functions as "an area-level marker of structural and financial barriers" to catching cancer early, rather than a direct biological cause. Lung cancer's outsized numbers, they suggested, may reflect that screening requires repeated annual imaging and follow-up scans on abnormal results, piling up costs even before a diagnosis is confirmed.

In an accompanying editorial, Nicole Mott, MD, MSCR, of the University of Colorado, and Fumiko Chino, MD, of MD Anderson Cancer Center, connected the dots further: medical debt is tied in other research to lower cancer screening rates and more deaths from screening-eligible cancers. Their read is that debt may stop people from getting screened or from following up on symptoms in the first place, leading to later diagnoses and worse survival odds down the line.

Limits of the data

This is an ecological, county-level study. It cannot confirm that the specific people carrying medical debt in a county are the same people showing up with stage IV cancer. Medscape's coverage flagged this directly, noting the design "limited causal inference" and that researchers lacked data on debt amounts relative to income, plus unmeasured confounders and within-county variation that could be driving the pattern instead of debt itself.

Correlation across nearly 3,000 counties with a consistent, statistically significant pattern across seven different cancer types is not nothing. But it's also not proof that forgiving debt or expanding coverage alone would move the needle on late-stage diagnoses.

Why insurance isn't the fix people think it is

The bigger problem this study points to, and one the Epoch Times laid out clearly, is that having insurance doesn't stop the debt in the first place. A Sept. 17 Commonwealth Fund survey of 4,000 people found a third of working-age insured Americans, including those on employer plans, individual plans, and ACA marketplace plans, already carry medical debt. Hospitals are the main creditor, cited by 64% of insured debt-holders, and 64% of those in debt blamed insurance companies directly.

Coverage denials are a huge part of the story. A June Commonwealth Fund study found at least one in five adults or their family members faced a coverage denial from July to October 2025. A separate KFF study put the insured denial rate at 33% between 2022 and 2024. Fewer than half of people who hit a billing error or denial even challenge it, mostly because they don't know they have the right to, per a 2024 Commonwealth Fund survey, and fewer than 1% of denied claims get appealed at all according to KFF.

Radiologybusiness also pointed to a real policy gap: the Affordable Care Act requires health plans to fully cover preventive screenings, but that mandate stops the moment a screening comes back abnormal. Follow-up diagnostic testing, the expensive part, isn't guaranteed coverage. Advocacy groups have pushed to redefine that follow-up testing as part of the "screening continuum," but no such federal requirement exists yet.

The current system lets people do everything right, get insured, get screened, and still end up financially exposed the moment a test comes back abnormal. Whether Congress or state insurance regulators move to close that diagnostic-coverage gap, or whether hospitals face any new pressure to rein in billing practices tied to the debt pileup documented by Commonwealth Fund, remains an open question with no legislation currently pending on it.